vs

Side-by-side financial comparison of Cardlytics, Inc. (CDLX) and HIVE Digital Technologies Ltd. (HIVE). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $50.9M, roughly 1.8× Cardlytics, Inc.). On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs -25.5%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs -9.6%).

Cardlytics is a leading purchase intelligence and advertising platform that partners with major banks to analyze anonymized consumer transaction data. It delivers targeted, performance-driven ad campaigns for consumer brands, retailers and service providers, helping advertisers reach audiences based on real purchase behavior, with core operations across North America and the United Kingdom.

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

CDLX vs HIVE — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.8× larger
HIVE
$93.1M
$50.9M
CDLX
Growing faster (revenue YoY)
HIVE
HIVE
+244.0% gap
HIVE
218.6%
-25.5%
CDLX
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
-9.6%
CDLX

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CDLX
CDLX
HIVE
HIVE
Revenue
$50.9M
$93.1M
Net Profit
$-91.3M
Gross Margin
-27.1%
Operating Margin
-12.0%
Net Margin
-98.1%
Revenue YoY
-25.5%
218.6%
Net Profit YoY
-234.0%
EPS (diluted)
$-0.15
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDLX
CDLX
HIVE
HIVE
Q4 25
$50.9M
$93.1M
Q3 25
$47.0M
$87.3M
Q2 25
$58.0M
$45.6M
Q1 25
$56.4M
Q4 24
$68.3M
$29.2M
Q3 24
$61.1M
$22.6M
Q2 24
$64.0M
$32.2M
Q1 24
$62.2M
Net Profit
CDLX
CDLX
HIVE
HIVE
Q4 25
$-91.3M
Q3 25
$-72.7M
$-15.8M
Q2 25
$-9.3M
$35.0M
Q1 25
$-13.3M
Q4 24
$68.2M
Q3 24
$-145.2M
$80.0K
Q2 24
$-4.3M
$-18.3M
Q1 24
$-24.3M
Gross Margin
CDLX
CDLX
HIVE
HIVE
Q4 25
-27.1%
Q3 25
4.7%
Q2 25
-13.6%
Q1 25
Q4 24
-43.7%
Q3 24
-66.1%
Q2 24
-7.4%
Q1 24
Operating Margin
CDLX
CDLX
HIVE
HIVE
Q4 25
-12.0%
Q3 25
-146.6%
Q2 25
-22.0%
Q1 25
-24.9%
Q4 24
-12.2%
Q3 24
-243.1%
Q2 24
-24.7%
Q1 24
-36.7%
Net Margin
CDLX
CDLX
HIVE
HIVE
Q4 25
-98.1%
Q3 25
-154.7%
-18.1%
Q2 25
-16.0%
76.8%
Q1 25
-23.5%
Q4 24
233.2%
Q3 24
-237.6%
0.4%
Q2 24
-6.7%
-56.7%
Q1 24
-39.0%
EPS (diluted)
CDLX
CDLX
HIVE
HIVE
Q4 25
$-0.15
$-0.38
Q3 25
$-1.36
$-0.07
Q2 25
$-0.18
$0.18
Q1 25
$-0.26
Q4 24
$-0.36
$0.52
Q3 24
$-2.90
$0.00
Q2 24
$-0.09
$-0.17
Q1 24
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDLX
CDLX
HIVE
HIVE
Cash + ST InvestmentsLiquidity on hand
$48.7M
Total DebtLower is stronger
$212.6M
Stockholders' EquityBook value
$-6.5M
$559.3M
Total Assets
$285.6M
$624.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDLX
CDLX
HIVE
HIVE
Q4 25
$48.7M
Q3 25
$44.0M
Q2 25
$46.7M
Q1 25
$52.0M
Q4 24
$65.6M
$40.5M
Q3 24
$67.0M
$31.7M
Q2 24
$71.2M
Q1 24
$97.8M
Total Debt
CDLX
CDLX
HIVE
HIVE
Q4 25
$212.6M
Q3 25
$214.6M
Q2 25
$214.3M
Q1 25
$213.9M
Q4 24
$213.6M
Q3 24
$213.2M
Q2 24
$212.9M
Q1 24
$257.9M
Stockholders' Equity
CDLX
CDLX
HIVE
HIVE
Q4 25
$-6.5M
$559.3M
Q3 25
$-4.7M
$624.6M
Q2 25
$58.7M
$560.5M
Q1 25
$64.1M
Q4 24
$70.0M
$430.9M
Q3 24
$69.7M
$275.5M
Q2 24
$210.0M
$268.6M
Q1 24
$199.1M
Total Assets
CDLX
CDLX
HIVE
HIVE
Q4 25
$285.6M
$624.0M
Q3 25
$292.8M
$693.0M
Q2 25
$361.1M
$628.7M
Q1 25
$369.1M
Q4 24
$392.7M
$478.6M
Q3 24
$399.4M
$334.7M
Q2 24
$534.4M
Q1 24
$569.0M
Debt / Equity
CDLX
CDLX
HIVE
HIVE
Q4 25
Q3 25
Q2 25
3.65×
Q1 25
3.34×
Q4 24
3.05×
Q3 24
3.06×
Q2 24
1.01×
Q1 24
1.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDLX
CDLX
HIVE
HIVE
Operating Cash FlowLast quarter
$13.0M
$46.0M
Free Cash FlowOCF − Capex
$13.0M
FCF MarginFCF / Revenue
25.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDLX
CDLX
HIVE
HIVE
Q4 25
$13.0M
$46.0M
Q3 25
$1.8M
$-10.6M
Q2 25
$1.2M
$10.2M
Q1 25
$-6.7M
Q4 24
$3.0M
$-28.5M
Q3 24
$1.4M
$-2.2M
Q2 24
$4.4M
$-4.4M
Q1 24
$-17.6M
Free Cash Flow
CDLX
CDLX
HIVE
HIVE
Q4 25
$13.0M
Q3 25
$1.7M
Q2 25
$903.0K
Q1 25
$-6.8M
Q4 24
$2.9M
$-55.5M
Q3 24
$878.0K
$-34.7M
Q2 24
$4.1M
Q1 24
$-18.3M
FCF Margin
CDLX
CDLX
HIVE
HIVE
Q4 25
25.5%
Q3 25
3.7%
Q2 25
1.6%
Q1 25
-12.1%
Q4 24
4.2%
-189.9%
Q3 24
1.4%
-153.4%
Q2 24
6.5%
Q1 24
-29.4%
Capex Intensity
CDLX
CDLX
HIVE
HIVE
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.6%
Q1 25
0.2%
Q4 24
0.2%
92.5%
Q3 24
0.8%
143.9%
Q2 24
0.4%
Q1 24
1.0%
Cash Conversion
CDLX
CDLX
HIVE
HIVE
Q4 25
Q3 25
Q2 25
0.29×
Q1 25
Q4 24
-0.42×
Q3 24
-26.94×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons